NYXOAH SA (NYXH.BR) Stock Price & Overview
EBR:NYXH • BE0974358906
Current stock price
The current stock price of NYXH.BR is 2.69 EUR. Today NYXH.BR is down by -3.58%. In the past month the price increased by 2.95%. In the past year, price decreased by -48.14%.
NYXH.BR Key Statistics
- Market Cap
- 117.445M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -2.36
- Dividend Yield
- N/A
NYXH.BR Stock Performance
NYXH.BR Stock Chart
NYXH.BR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to NYXH.BR. When comparing the yearly performance of all stocks, NYXH.BR is a bad performer in the overall market: 97.25% of all stocks are doing better.
NYXH.BR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to NYXH.BR. NYXH.BR may be in some trouble as it scores bad on both profitability and health.
NYXH.BR Earnings
On March 19, 2026 NYXH.BR reported an EPS of -0.59 and a revenue of 5.64M. The company missed EPS expectations (-5.5% surprise) and beat revenue expectations (20.65% surprise).
NYXH.BR Forecast & Estimates
14 analysts have analysed NYXH.BR and the average price target is 8.93 EUR. This implies a price increase of 231.78% is expected in the next year compared to the current price of 2.69.
For the next year, analysts expect an EPS growth of 18.35% and a revenue growth 252.82% for NYXH.BR
NYXH.BR Groups
Sector & Classification
NYXH.BR Financial Highlights
Over the last trailing twelve months NYXH.BR reported a non-GAAP Earnings per Share(EPS) of -2.36. The EPS decreased by -31.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -76.04% | ||
| ROE | -183.36% | ||
| Debt/Equity | 0.37 |
NYXH.BR Ownership
NYXH.BR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1MDT | MEDTRONIC PLC | 14.15 | 94.93B | ||
| 2M6 | MEDTRONIC PLC | 13.59 | 91.207B | ||
| SHL | SIEMENS HEALTHINEERS AG | 13.71 | 41.589B | ||
| PHIA | KONINKLIJKE PHILIPS NV | 15.68 | 23.303B | ||
| PHI1 | KONINKLIJKE PHILIPS NV | 15.96 | 23.293B | ||
| BIM | BIOMERIEUX | 15.28 | 10.505B | ||
| OBCK | OTTOBOCK SE & CO KGAA | 19.5 | 3.763B | ||
| DIA | DIASORIN SPA | 15.02 | 3.502B | ||
| AFX | CARL ZEISS MEDITEC AG - BR | 14.32 | 2.481B | ||
| DRW3 | DRAEGERWERK AG - PREF | 11.63 | 1.8B | ||
| DRW8 | DRAEGERWERK AG | 9 | 1.392B | ||
| ELN | EL.EN. SPA | 17.42 | 1.057B | ||
| EUZ | ECKERT & ZIEGLER SE | 18.5 | 952.8M |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Brussels Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About NYXH.BR
Company Profile
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 184 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Company Info
IPO: 2020-09-18
NYXOAH SA
Rue Edouard Belin 12
Mont-Saint-Guibert BRABANT-WALLON BE
Employees: 184
Phone: 3226121755
NYXOAH SA / NYXH.BR FAQ
What does NYXH do?
Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 184 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
What is the stock price of NYXOAH SA today?
The current stock price of NYXH.BR is 2.69 EUR. The price decreased by -3.58% in the last trading session.
Does NYXH stock pay dividends?
NYXH.BR does not pay a dividend.
What is the ChartMill rating of NYXOAH SA stock?
NYXH.BR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is NYXOAH SA (NYXH.BR) stock traded?
NYXH.BR stock is listed on the Euronext Brussels exchange.
What is the market capitalization of NYXH stock?
NYXOAH SA (NYXH.BR) has a market capitalization of 117.45M EUR. This makes NYXH.BR a Micro Cap stock.